Skip to main content
. Author manuscript; available in PMC: 2008 Mar 1.
Published in final edited form as: Exp Neurol. 2006 Nov 22;204(1):171–181. doi: 10.1016/j.expneurol.2006.10.006

Table 1.

SCI subjects' characteristics1

S# Gender Age (years) Post-injury (months) Ashworth score ASIA Lesion level Sensation Spasms/Clonus Medication per day Range of movement (ROM) at the hip
S1 M 35  96 1 C C5 Intact Extensor crossed – 43°
S3 M 29  36 0 C C5 Intact Frequent – 45°
S4 M 47  78 2 C C6 Intact Ankle clonus Baclofen 60 mg 55°
S5 M 22  45 2 C T11 Intact Ankle clonus Baclofen 20 mg 65°
S7 F 61  50 0 C T9 Intact Spasms present – 57°
S10 M 52 210 1 C C5 No sensation of cold/warm Ankle clonus Baclofen 30 mg 55°
S11 M 52 186 3 C C5 No sensation of cold/warm Extensor spasms Ankle clonus – 60°
S12 M  36 36 2 B T8 Intact Severe flexor spasms Baclofen pump 58°
1

Lesion completeness was classified according to the ASIA impairment scale (Maynard et al., 1997) with ASIA C representing a sensory and motor incomplete lesion where more than half of muscles below the injury level have strength of less than 3 out of 5, and ASIA B representing sensory incomplete but motor complete spinal cord lesion. Spasticity at the ankle was scaled according to the Ashworth scale (Ashworth, 1964). S#: subject number; F, Female; M, Male.